(+34) 93 414 55 66
Contact
Espacio socios y amigos
Main structural lines
The Josep Carreras Leukaemia Research Institute grows year after year
The figures for the end of 2022 are:
TECHNICIANS
0
RESEARCHERS
0
RESEARCH GROUPS
0
TECHNOLOGY PLATFORM STAFF
0
RESEARCH GROUPS
0
Research groups
Genesis of cancer
Cancer Epigenetics
Manel Esteller
Group leader
Cancer genetics
Montse Sanchez-Cespedes
Group leader
Epigenetics and immune diseases
Esteban Ballestar
Group leader
Regulatory genomics
Tanya Vavouri
Group leader
Chromatin and RNA Regulator
Sonia Guil
Group leader
Cancer Immunogenomics
Eduard Porta
Group leader
Cancer heterogeneity and hierarchies
Verónica Rodilla
Group leader
Endothelial pathobiology and microenvironment
Mariona Graupera
Group leader
Cancer Metabolism
Lucas Pontel
Group leader
Epigenetic therapies
María Berdasco
Group leader
Immunohaematology and glycobiology
Fumiichiro Yamamoto
Group leader
Lymphoid Neoplasms
Acute Lymphoblastic Leukaemia (ALL)
José María Ribera
Group leader
3D Chromatin organisation
Biola M Javierre
Group leader
Cellular immunotherapy and gene therapy
Javier Briones
Group leader
Cell system genomics
Elisabetta Mereu
Group leader
Chromatin biology laboratory
Alex Vaquero
Group leader
Chronic lymphocytic leukaemia
Carolina Moreno
Group leader
Development and Lymphocytic diseases
Maribel Parra
Group leader
Lymphoid Neoplasms
Tomás Navarro
Group leader
Translational lymphoma research
Gaël Roué
Group leader
Mechanisms of Cancer and Ageing (South)
Salvador Macip
Group leader
Multiple myeloma
Albert Oriol
Group leader
Nuclear Architecture of Leukaemia
Gregoire Stik
Group leader
Stem cell biology, developmental leukaemia and immunotherapy
Pablo Menéndez
Group leader
Stem cells and cancer
Anna Bigas
Group leader
T-cell lymphoma
Laura Mondragón
Group leader
Myeloid Neoplasms
Chromatin, metabolism and cell fate
Marcus Buschbeck
Group leader
Descriptive epidemiology, genetics and cancer prevention
Rafael Marcos-Gragera
Group leader
Epigenetic haematopoiesis control
José Luis Sardina
Group leader
Myeloid Neoplasms
Lurdes Zamora
Group leader
Haematological diagnosis
Josep Nomdedéu
Group leader
Haematological diseases, transplant and cell therapy
Jordi Sierra
Group leader
Leukaemia and immuno-oncology
Laura Belver
Group leader
Myelodysplastic syndromes
Francesc Solé
Group leader
Myeloid Neoplasms - Clínic
Jordi Esteve Reyner
Group leader
Oncogenesis and anti-tumour drugs
Ramon Mangues
Group leader
Transcriptional Dynamics of Leukaemia
Sergi Cuartero
Group leader
Transplant and immunotherapy
Barcelona Endothelium Team (BET)
Enric Carreras
Group leader
Haematology
David Gallardo
Group leader
Stem cell transplant and cellular immunotherapy
Álvaro Urbano-Ispizua
Group leader
Become a member of the cure for leukaemia!